GlassScriptPhysician profile
Karmen Lynn Serda
NPI 1861086068
$3,777.15
in general payments reported to CMS, 2019-2025
21 companies · $692 in 2025
The $692 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $644 · 2022: $1,785 · 2023: $408 · 2024: $248 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,348.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,499.80 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $320.71 | 2022 | |
| Eisai INC. | $320.49 | 2025 | |
| Lilly USA, LLC | $303.04 | 2022-2025 | Kisunla |
| Amneal Pharmaceuticals LLC | $182.35 | 2021-2022 | |
| Amgen INC. | $168.14 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $162.30 | 2021 | |
| Avanir Pharmaceuticals, INC. | $117.75 | 2022 | |
| Sk Life Science, INC. | $109.97 | 2021-2022 | |
| Nevro Corp. | $104.58 | 2022 | |
| Ucb, INC. | $95.26 | 2022-2023 | Cimzia |
| Biogen, INC. | $74.03 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $66.58 | 2022 | |
| Kyowa Kirin, INC. | $59.07 | 2022 | |
| Avion Pharmaceuticals | $56.53 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $44.41 | 2022 | |
| Pfizer INC. | $32.16 | 2023-2024 | |
| Haemonetics Corporation | $17.72 | 2025 | Teg6s Hemostasis System |
| Pacira Pharmaceuticals Incorporated | $17.17 | 2022 | |
| Lundbeck LLC | $12.83 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karmen Serda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.